Acutus Medical
Acutus Medical, founded in 2011 and based in San Diego, CA, specializes in advanced cardiac mapping and ablation technologies, including the AcQMap System and AcQBlate FORCE Sensing Ablation Catheter, to support personalized arrhythmia treatment.
Services
Acutus Medical offers various services focused on personalized ablation strategies for arrhythmia management. Using advanced technologies like the AcQMap System, AcQBlate FORCE Sensing Ablation Catheter, and non-contact trigger mapping workflow, the company provides personalized therapy guidance. The company's solutions aim to improve the diagnosis, visualization, and treatment of complex arrhythmias through real-time visualization and automated analysis tools.
Products
Acutus Medical's product lineup includes the AcQMap System, AcQBlate FORCE Sensing Ablation Catheter, AcQTrack analysis tool, SlowZone analysis tool, AcQMap 3D Imaging + Mapping Catheter, AcQMap Patient Electrode Kit, AcQGuide MAX Steerable Sheath, AcQCross Integrated Transseptal Dilator/Needle, and AcQRef Introducer Sheath. These products are co-developed in the U.S. and Europe, focusing on high-resolution, real-time mapping and efficient, safe ablation strategies for arrhythmia treatment.
Technology
The AcQMap System is a core technology from Acutus Medical, capable of acquiring over 115,000 ultrasound data points per minute for real-time, non-contact mapping of the heart chamber. It supports multiple mapping modes, including Non-contact, SuperMap, and Contact modes, and provides detailed views of endocardial activation with real-time arrhythmia visualization. The system is designed to map any rhythm within 3 minutes and offers high resolution for both stable and unstable rhythm patterns.
History
Acutus Medical was founded in 2011 and is headquartered in San Diego, CA. Since its inception, the company has focused on developing innovative technology and products for the treatment of complex arrhythmias. Acutus Medical's solutions have been co-developed in collaboration with partners in both the U.S. and Europe, ensuring high-quality and cutting-edge advancements in arrhythmia management.